Pharmaceuticals
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Genovate Biotech (TPEX:4130) subsidiary andTaiwan-based?focused ultrasound (FUS) manufacturer NaviFUS Corporation is pleased to announce the start of its clinical trial (NCT04446416) for the combination of FUS?plus?bevacizumab therapy. Researchers at Linkou ...
2020-09-11 20:55
4307
In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data f...
2020-09-11 20:00
6109
CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ --? Sai Life Sciences, one ofIndia's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today ann...
2020-09-11 11:30
4866
COLUMBIA, Md., Sept. 11, 2020 /PRNewswire/ -- Movilitas announced Pharmalutions Pte Ltd as its newest Movilitas.Cloud partner for theAsia-Pacific region. Under the partnership, Pharmalutions provides greater access to compliance-ready solutions with Movilitas.Cloud, a GAMP 5 validated software as...
2020-09-11 10:38
3700
LONDON, Sept. 11, 2020 /PRNewswire/ --?It is estimated that rates of resistance to commonly-used antibiotics could exceed 40–60% in some countries by 2030.1 ? With antimicrobial resistance (AMR) set to claim the lives of 10 million by 2050 if no action is taken,2?the GHC's experts are calling for ...
2020-09-11 07:01
4493
NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Tottenham Acquisition I Limited (Nasdaq: TOTA, TOTAU, TOTAW, TOTAR) ("Tottenham"), a publicly traded special purpose acquisition company, announced today that its subsidiary, Chelsea Worldwide Inc., has filed with the U.S. Securities and Exchange Commissio...
2020-09-10 20:56
21850
Not intended for UK and US based media - Sonelokinab is an investigational IL-17 A/F Nanobody?, which neutralizes both IL-17A and IL-17F - Phase II study was facilitated by Avillion as part of an innovative co-development model DARMSTADT, Germany, Sept. 10, 2020 /PRNewswire/ -- Merck, a leadin...
2020-09-10 20:00
3246
GERMANTOWN, Maryland, Sept. 10, 2020 /PRNewswire/ --?Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the last subject completed their final follow-up assessment in the Company's...
2020-09-10 20:00
3855
LONDON, Sept. 10, 2020 /PRNewswire/ --?Haoma Medica announced today that it will present three scientific posters on NaQuinate at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting, which this year takes place as a virtual event from the 11-15 September. NaQuinate, a n...
2020-09-10 17:34
3815
-? Creates one of the largest single-digit nanogram containment manufacturing facilities for high-potent active pharmaceutical ingredient (HPAPI) production -? Allows continuous flow manufacturing for antibody-drug conjugates (ADCs) -? Approximately 50 full-time jobs to be added DARMSTADT, Germ...
2020-09-09 21:00
4325
TAIZHOU,?China, Sept. 9,?2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...
2020-09-09 21:00
9798
SHANGHAI and TEL-AVIV, Israel, Sept. 9, 2020 /PRNewswire/ -- Gannex?Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announces today that they have entered into a research agreement aiming at combination therapy of ASC41 ...
2020-09-09 18:30
5313
-?Grand Slam winner Caroline Wozniacki is the highest-ranking female athlete known to have been diagnosed with rheumatoid arthritis whilst still playing professional tennis - Advantage Hers?will equip and empower women around the world living with chronic inflammatory diseases, such as rheumatoi...
2020-09-09 14:38
3442
FREDERICA, Delaware, Sept. 9, 2020 /PRNewswire/ --?ILC Dover, Inc. ("ILC Dover" or the "Company"), a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, today announced the acquisition of Solo Containment, Ltd. ("Solo"...
2020-09-09 13:00
3798
... 333
Week's Top Stories
Most Reposted
[Picked up by 298 media titles]
2025-09-04 15:41[Picked up by 276 media titles]
2025-09-04 14:02[Picked up by 274 media titles]
2025-09-06 17:47[Picked up by 274 media titles]
2025-09-03 17:42[Picked up by 270 media titles]
2025-09-04 09:30Most Read
2025-09-03 18:30
4393
2025-09-03 16:42
3574
2025-09-06 04:30
3287
2025-09-02 20:30
3098
2025-09-04 20:17
3068